GBS Inc. (GBS): Price and Financial Metrics
GBS Price/Volume Stats
| Current price | $0.47 | 52-week high | $2.89 |
| Prev. close | $0.47 | 52-week low | $0.36 |
| Day low | $0.45 | Volume | 11,000 |
| Day high | $0.49 | Avg. volume | 955,325 |
| 50-day MA | $0.52 | Dividend yield | N/A |
| 200-day MA | $0.71 | Market Cap | 7.05M |
GBS Stock Price Chart Interactive Chart >
GBS Inc. (GBS) Company Bio
GBS Inc. operates as a biosensor diagnostic technology company. Its principal product is Saliva Glucose Biosensor, a saliva glucose monitoring system for diabetes management. The company also focuses on developing other diagnostic tests in the areas of biochemistry, tumor markers, immunology, hormones, and other biomarkers. It operates in Mainland China, Hong Kong, Vietnam, and Bangladesh. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was founded in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
GBS Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -19.27% |
| 5-year | N/A |
| YTD | N/A |
| 2024 | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -80.61% |
| 2020 | N/A |
Loading social stream, please wait...